Breaking News
November 19, 2017 - UNN researchers explore modeling of cognitive dissonance phenomenon
November 19, 2017 - Verseon presents second anticoagulation candidate for clinical trials at AHA 2017
November 19, 2017 - Pregnant Asian women who develop high blood pressure at highest risk for heart failure hospitalization
November 19, 2017 - Medicare seeks comment on ways to cut costs of Part D drugs
November 19, 2017 - Tree cover linked to fewer asthma cases in polluted urban neighborhoods
November 19, 2017 - Make the Diagnosis: Hair Care Conundrum
November 19, 2017 - New techniques give blood biopsies greater promise
November 19, 2017 - Researchers identify possible genetic basis for coronary artery disease
November 19, 2017 - Stress experienced by emergency call handlers has negative impact on psychological health
November 18, 2017 - New cancer cell screening is improving childhood leukaemia treatment
November 18, 2017 - Groundbreaking study identifies protein as potential factor in cancer metastasis
November 18, 2017 - New model to test effectiveness of existing and potential CF therapies
November 18, 2017 - Staying Active May Lower Odds for Glaucoma
November 18, 2017 - Potential new autism drug shows promise in mice
November 18, 2017 - Some states roll back ‘retroactive Medicaid,’ a buffer for the poor — and for hospitals
November 18, 2017 - Selectively deleting stem cell factor promotes recovery after TBI in mice
November 18, 2017 - Breakthrough research brings new procedure closer to helping patients with blood cancer
November 18, 2017 - Dr Peter Simpson Appointed to SLAS Board of Directors
November 18, 2017 - Friendships between young children can protect against ADHD
November 18, 2017 - Old World monkeys could hold key to stop progression of rheumatoid arthritis
November 18, 2017 - Harris Health System RNs named among 20 Outstanding Nurses for 2017
November 18, 2017 - Old World monkeys could be key to a new, powerful rheumatoid arthritis therapy
November 18, 2017 - Mount Sinai researchers identify new therapeutic target for ER+ breast cancer
November 18, 2017 - Age, CRP levels predict success in tapering of biologics in rheumatoid arthritis patients
November 18, 2017 - New dye could be used to observe electrical activity of neurons in the brain
November 18, 2017 - New study further validates use of vaginal progesterone to decrease risk of preterm birth
November 18, 2017 - Russian researcher determined range of reference values for boron in the human body
November 18, 2017 - ‘What the Health?’ Tax bill or health bill?
November 18, 2017 - Could Your Cat Give You ‘Bird Flu?’
November 18, 2017 - Vitamin D Linked to Fertility Outcomes in ART
November 18, 2017 - Neuroscientists identify genetic changes in microglia in a mouse model of neurodegeneration and Alzheimer’s disease
November 18, 2017 - Tax reform proposal could impact care for older Americans
November 18, 2017 - PCSK9 inhibitor offers clinical benefit to patients with peripheral artery disease
November 18, 2017 - Researchers receive £1.3 million to develop sight-saving imaging technology
November 18, 2017 - Novel buckypaper sensor could pave way for high-performance, affordable wearable technology
November 18, 2017 - Despite ACA cost protections, most adolescents skip regular checkups
November 18, 2017 - Stem cell treatment allows paraplegic rats to walk and regain sensory perception
November 18, 2017 - HTC analytical conference comes to the UK
November 18, 2017 - Face It: Drinking, Smoking Takes Toll on Looks: MedlinePlus Health News
November 18, 2017 - New research shows where in the brain the earliest signs of Alzheimer’s occur
November 18, 2017 - Philips announces launch of global movement to raise awareness for COPD
November 18, 2017 - University of Bristol awarded grant to reduce antibacterial drug resistance in Thailand
November 18, 2017 - New oxytocin chemical sensor could be first step towards early diagnosis of autism
November 18, 2017 - Study shows how naïve T-cells may affect tumor immunity and immunotherapy
November 18, 2017 - New studies highlight importance of cardiorespiratory fitness to reduce CVD risk
November 18, 2017 - Study finds medical cannabis is effective at reducing opioid addiction
November 18, 2017 - Specially tailored, ultrafast light pulses can trigger neurons to fire in different patterns
November 18, 2017 - Decrease in sunshine linked to rising incidence of Rickets
November 18, 2017 - Harnessing social media big data to fight against prescription drug crisis
November 18, 2017 - Researchers find way to switch tumor cells between 2D and 3D morphology
November 18, 2017 - Leaf-eating ability of beetle largely due to bacteria inside the insect
November 18, 2017 - FDA Approves Hemlibra (emicizumab-kxwh) for Hemophilia A with Inhibitors
November 18, 2017 - Adolescents underreport amphetamine use, likely unaware that adderall is amphetamine
November 18, 2017 - Study reveals a reduced risk of teenage eczema in breastfed babies
November 18, 2017 - Separating side effects could pave way for safe, effective pain medications
November 18, 2017 - Gut bacteria at young age can contribute to MS disease onset and progression, study suggests
November 18, 2017 - Environmental triggers may play role in development of Lupus
November 18, 2017 - Review looks into conventional versus new treatment modalities in orthodontic pain management
November 17, 2017 - FDA Alert: Diphenoxylate Hydrochloride and Atropine Sulfate Tablets by Greenstone: Recall
November 17, 2017 - For older women, every movement matters
November 17, 2017 - Talking-based therapy could transform aftercare for cancer survivors
November 17, 2017 - Olympus IXplore SpinSR10 imaging system enables researchers to observe fine details in live cells
November 17, 2017 - Study explores reasons for underrepresentation of minorities in genetic cancer research
November 17, 2017 - California firm running physician practices is closing down as scrutiny ramps up
November 17, 2017 - BMI not valid measure of obesity in postmenopausal women, study shows
November 17, 2017 - Vaginal progesterone decreases the risk of premature birth in women with short cervix
November 17, 2017 - Pricey ER Tests for Chest Pain Often Unnecessary
November 17, 2017 - ‘Old’ Lungs May Be Good Transplant Options: MedlinePlus Health News
November 17, 2017 - How not to gain weight over the holidays
November 17, 2017 - Researchers map first-ever proteome of healthy human heart
November 17, 2017 - Drug used to prevent and treat malaria may also be effective for Zika virus
November 17, 2017 - One in 20 children still receiving codeine to treat pain despite warning from federal regulators
November 17, 2017 - Improving clinical trials with machine learning
November 17, 2017 - Experts identify mental exercise program that can reduce risk of dementia
November 17, 2017 - Just-in-time 3-D implants set to transform tumor surgery
November 17, 2017 - Skin patch offers hope for people with peanut allergy
November 17, 2017 - Scientists identify biomarkers that predict risk of death in Ebola patients
November 17, 2017 - Heart attack, stroke patients have improved outcomes when statins are prescribed after discharge
November 17, 2017 - Majority of people do not understand link between obesity and cancer, study shows
November 17, 2017 - Deep vein thrombosis accurately diagnosed by GPs trained in compression ultrasonography
Financial savings lower than anticipated for generic oral chemotherapy

Financial savings lower than anticipated for generic oral chemotherapy

image_pdfDownload PDFimage_print

A find out about by means of researchers on the College of North Carolina Eshelman College of Pharmacy and Lineberger Complete Most cancers Heart made up our minds the associated fee financial savings for a generic model of an orally administered most cancers remedy have been lower than anticipated—a discovering that questions the affect generic medicine may have on controlling well being care prices.

The researchers record within the JAMA Inner Medication that the associated fee for one fill of the generic type of the chemotherapy remedy capecitabine used to be $2,328 remaining yr. That value used to be 36 % not up to the projected branded drug value in 2016—a financial savings the researchers deemed modest in comparison to discounts observed for different generic medicine.

“For this oral most cancers remedy, we do not see the extent of value relief that we might be expecting for generic drug access,” mentioned the find out about’s senior creator Stacie Dusetzina, PhD, a UNC Lineberger member and assistant professor within the UNC Eshelman College of Pharmacy.

Dusetzina mentioned pageant from generic medicine has been a very powerful instrument for curtailing clinical prices and increasing remedy get right of entry to. On the identical time, corporations would possibly use generic value discounts as a rationale for environment upper costs for brand-name medicine, with the justification that costs can be considerably decrease after generics input the marketplace.

Capecitabine used to be one of the most first high-priced, orally administered most cancers remedies to lose patent coverage in the USA, the researchers record. They discovered that will increase in the cost of the brand-name drug, and a smaller-than-expected relief in the cost of the generic variations of the remedy, reduced the affect of generic pageant on costs 3 years after the brand-name drug got here off patent.

“The usage of capecitabine as a case find out about for the possible impact of generic pageant for orally-administered anti-cancer remedies, we discovered that discounts within the listing value have been extra modest than the ones noticed for different medicine with the similar collection of generic marketplace competition,” mentioned the find out about’s first creator Ashley Cole, MPH, a doctoral pupil and graduate analysis assistant within the UNC Eshelman College of Pharmacy.

The researchers used industrial insurance coverage claims information to estimate prescription costs for branded and generic capecitabine between 2002 and 2016. Capecitabine misplaced patent coverage in 2013, and in step with the researchers’ information, the primary fill for the generic selection used to be in March of 2014. The cost of a typical one-month provide of generic capecitabine averaged $2,598 in 2014, best 17 % under the projected branded drug value. By means of 2016, the typical generic value dropped to $2,328, which used to be 36 % under the projected branded drug value. Different research have discovered better financial savings for generic access, even in settings with a identical collection of competition.

In addition they made up our minds that brand-name drug costs larger over the years, and generic costs adopted go well with. In 2016, the cost of the generic capecitabine used to be very similar to the listing value of the brand-name drug in 2010, and it used to be 70 % upper than the brand-name drug’s listing value in 2002.

“The cost of capecitabine has greater than doubled since 2002, so even after generic access, the fee paid by means of well being plans continues to be upper than the branded drug’s authentic listing value after you alter for inflation,” Dusetzina mentioned. “If costs after generic access are in the end upper than authentic listing costs, then it’s not transparent that sufferers could have more uncomplicated get right of entry to to remedy following generic access.”

On this find out about of commercially insured sufferers, maximum sufferers had decrease out-of-pocket prices after generic access. On the other hand, about 10 % of folks paid greater than $100 for one fill of the drugs.

“As we see extra sufferers enrolled in excessive deductible well being plans, paying deductibles or co-insurance for his or her medicine, this loss of value relief would possibly without delay affect sufferers,” Dusetzina mentioned.

The findings will have coverage implications. Encouraging tough generic pageant may assist keep an eye on well being care prices, Dusetzina mentioned, because the collection of producers providing generic merchandise has been discovered to be similar to worth discounts.

“There may be an ongoing nationwide dialog round prescription drug costs, specifically forte medicine, like the ones utilized in oncology,” Cole mentioned. “Some have prompt that generic price cutting war can be a market-based option to this drawback. Our find out about supplies early proof that generic pageant by myself is probably not sufficient to rein within the excessive costs for orally administered most cancers remedies.”


Discover additional:
FDA takes steps to spice up generic pageant, prohibit costs

Magazine reference:
JAMA Inner Medication

Equipped by means of:
UNC Lineberger Complete Most cancers Heart

Tagged with:

About author

Related Articles